Clinical trial
Proteomic Analysis and Clinical Efficacy Evaluation of Hemoadsorption Therapy in Sepsis
NCT07865585 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Proteomic Analysis and Clinical Efficacy Evaluation of Hemoadsorption Therapy in Sepsis
- Lead sponsor
- Shanghai Zhongshan Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- October 1, 2026
- Completion date
- March 31, 2028
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sepsis and septic shock